Chlamydial infection of the host cell induces Gamma interferon (IFNc), a central immunoprotector for humans and mice. The primary defense against Chlamydia infection in the mouse involves the IFNc-inducible family of IRG proteins; however, the precise mechanisms mediating the pathogen's elimination are unknown. In this study, we identify Irga6 as an important resistance factor against C. trachomatis, but not C. muridarum, infection in IFNc-stimulated mouse embryonic fibroblasts (MEFs). We show that Irga6, Irgd, Irgm2 and Irgm3 accumulate at bacterial inclusions in MEFs upon stimulation with IFNc, whereas Irgb6 colocalized in the presence or absence of the cytokine. This accumulation triggers a rerouting of bacterial inclusions to autophagosomes that subsequently fuse to lysosomes for elimination. Autophagy-deficient Atg52/2 MEFs and lysosomal acidification impaired cells surrender to infection. Irgm2, Irgm3 and Irgd still localize to inclusions in IFNcinduced Atg52/2 cells, but Irga6 localization is disrupted indicating its pivotal role in pathogen resistance. Irga6-deficient (Irga62/2) MEFs, in which chlamydial growth is enhanced, do not respond to IFNc even though Irgb6, Irgd, Irgm2 and Irgm3 still localize to inclusions. Taken together, we identify Irga6 as a necessary factor in conferring host resistance by remodelling a classically nonfusogenic intracellular pathogen to stimulate fusion with autophagosomes, thereby rerouting the intruder to the lysosomal compartment for destruction.
Introduction
Chlamydiae are obligate intracellular pathogens that cause a variety of infections in humans and animals. Chlamydia trachomatis is a primarily human pathogen associated with common sexually transmitted diseases and trachoma [1] . Chlamydiae undergo a unique biphasic developmental cycle that alternates between extracellular infectious, metabolically inert elementary bodies (EBs) and the intracellular non-infectious, metabolically active, multiplying reticulate bodies (RBs) [2, 3] . Bacteria enter the host cell and survive within a membrane-bound vacuole, termed the inclusion, in which they ensure their successful propagation by avoiding fusion with lysosomes [4, 5] . Non-fusogenity with lysosomes is controlled by the mode of cellular uptake [6, 7] and chlamydial protein factors [8, 9] .
Gamma interferon (IFNc) plays a central role in innate immunity against intracellular pathogens. It induces the expression of more than 1,200 genes, a number of which include effectors that function to eradicate pathogens from host cells. Their activation leads to a depletion of the tryptophan (Trp) pool [10] , production of toxic nitric oxide [11] , deprivation of intracellular iron pools [12] and induction of host autophagy [13, 14] . Among the genes highly induced by IFNc are the immunity-related GTPases (IRGs; also known as small p47 GTPases), reviewed in [1, [15] [16] [17] [18] .
Recent work has indicated the involvement of several mouse IRG proteins in the growth regulation of pathogens within IFNcinduced host cells: for instance, Irgm1 stimulates IFNc-induced control of Mycobacterium tuberculosis and Trypanosoma cruzi in macrophages [19] and Irgm3 regulates IFNc-induced control of C. trachomatis in fibroblasts [20] . Irgm3-, Irgd-and Irgm1-knockout mice displayed reduced resistance to several bacterial and protozoan pathogens despite an immune response and IFNc production [21, 22] . This strong correlation between loss of resistance in intact mice and loss of IFNc-induced control in cultured host cells suggests eliminating pathogens from host cells is a major function of these proteins.
IRG proteins localize predominantly to the endoplasmic reticulum (ER) (Irga6 and Irgm3), the Golgi (Irga6, Irgm1 and Irgm2), the plasma membrane and in nascent pathogen-containing vacuoles or phagosomes [reviewed in [16] [17] [18] . The localization of IRGs to pathogen-containing vacuoles in host cells suggests that they restrict pathogen growth by vacuole processing. IRGs have been shown to drive vacuole acidification and fusion with lysosomes in M. tuberculosis [19] , to disrupt the vacuolar membrane in Toxoplasma gondii [23, 24] and to eliminate mycobacteria containing vacuoles through regulating IFNc-induced autophagy [13, 14] .
Autophagy is an evolutionary conserved lysosomal degradation pathway that maintains cellular homeostasis and selectively disposes of intracellular pathogens [13, 25, 26] . Not only intracellular pathogens residing in the cytosol, but also pathogens residing in membranous or intravacuolar compartments are sequestered into autophagosomes for degradation in autolysosomes, as shown for T. gondii [23, 27] .
Chlamydiae exhibit a wide range of host tropism that has been linked to differences in immune responses elicited by IFNc [28] . In human cells, IFNc can effectively suppress growth of C. trachomatis and C. muridarum by activating indolamine dioxygenase, which deprives both of essential Trp. However, in murine genital epithelial cells (MECs), IFNc can restrict growth of C. trachomatis, but not C. muridarum [28] . Growth inhibition of C. trachomatis in mouse cells is Trp depletion independent and is largely attributed to the IFNc-inducible IRGs. Little is known about the cellular functions of mouse IRGs in host resistance against Chlamydia species. A role for Irga6 in controlling pathogen growth upon IFNc stimulation in MECs was demonstrated by RNA silencing of Irga6, which led to increased C. trachomatis survival [28] . However, the major effector mechanism(s) by which IRGs control chlamydial infection remain elusive.
Here we investigated the immunoprotective role of IRGs in C. trachomatis infection of murine cells and in the IFNc-insensitive mouse strain C. muridarum. We show that C. trachomatis growth is arrested by the development of early inclusions with autolysosomal features. In contrast, C. muridarum inclusions remained segregated from lysosomes and autophagosomes. Subcellular analysis revealed that C. trachomatis inclusions sequestered Irga6, Irgd, Irgm2 and Irgm3 in response to IFNc blocking chlamydial growth. However, autophagy-deficient cells tolerated C. trachomatis infection despite an accumulation of Irgd, Irgm2 and Irgm3 at inclusions. Strikingly, Irga6 did not associate with inclusions in autophagy-deficient cells. In addition, Irga62/2 MEFs did not respond to IFNc and did not restrict C. trachomatis growth, although Irgd, Irgm2 and Irgm3 localized to inclusions. Thus, our data indicate that Irga6 modifies the inclusion membrane to mediate fusion with autophagosomes as a mechanism to dispose of C. trachomatis.
Results
IFNc negatively affects the growth of C. trachomatis, but not of C. muridarum in MEFs IFNc is a critical mediator for controlling chlamydial infection. To assess the effect of IFNc on chlamydial growth in mouse embryonic fibroblasts (MEFs), cells were infected with C. trachomatis LGV L2 or C. muridarum at a multiplicity of infection (MOI) of 1 for 2 h. Following 48 h incubation in the presence of IFNc, cells were immunostained and analyzed by microscopy. IFNc treatment resulted in much smaller and substantially reduced numbers of C. trachomatis inclusions ( Figure 1A) . Similar results were obtained from the pretreated cells with IFNc. Furthermore, a reduction of infectious C. trachomatis EBs of more than 70% as compared to non-treated infected MEFs ( Figure 1B ) was found. In contrast, IFNc affected neither inclusion development nor formation of infectious progeny of C. muridarum ( Figure 1C and  D) . Thus, distinct chlamydial species exhibit differential sensitivities to IFNc in host resistance: Growth of C. trachomatis in MEFs is arrested in response to IFNc, whereas growth of C. muridarum is not affected in response to IFNc.
Irga6, Irgd, Irgm2 and Irgm3 interact specifically with early C. trachomatis inclusions in response to IFNc
Since IFNc can upregulate IRG expression in C. trachomatis infected murine cells [28] , we investigated the involvement of IRGs in IFNc-mediated inhibition of chlamydial growth. Untreated and IFNc-pretreated MEFs were infected with C. trachomatis or C. muridarum (MOI 5) in the presence of IFNc. Three hours post infection (h p.i.) cells were processed for indirect immunofluorescence to analyze colocalization of early chlamydial inclusions with IRGs ( Figure 2A ). Upon IFNc treatment C. trachomatis inclusions colocalized to a high degree with IRGs: Irga6 (83%), Irgd (49%), Irgm2 (74%) and Irgm3 (87%). Surprisingly, Irgb6 also colocalized with inclusions in both treated (63%) and untreated cells, whereas Irgm1 colocalization was minimal ( Figure 2B ). However, no localization of IRGs to C. muridarum inclusions was detected ( Figure S1A ). Thus, IFNc stimulation leads to a specific modification of C. trachomatis inclusions by recruiting four different IRGs.
IFNc stimulates C. trachomatis elimination by lysosomal fusion with early inclusions
We next investigated whether IRG-positive C. trachomatis inclusions are directed to lysosomes for degradation. First we monitored colocalization of inclusions with the lysosomal marker LAMP1 at 3 h p.i. In control, untreated MEFs, only 20% of inclusions colocalized with LAMP1. In contrast, LAMP1 colocalization in inclusions of IFNc-treated cells was increased 4-fold ( Figure 3A and B). Consistent with an ability to grow in the presence of IFNc, no LAMP1 colocalization with C. muridarum inclusions was observed in untreated or IFNc-treated cells ( Figure  S2A and B). To confirm that IFNc-induced phagosome-lysosome fusion eliminates C. trachomatis, we studied the effect of inhibiting lysosomal acidification with bafilomycin A1 (Baf A1), a specific vacuolar H + -ATPase inhibitor. Growth of C. trachomatis inclusions was rescued and formation of infectious EBs increased upon Baf treatment ( Figure 3C and D). These data clearly indicate that lysosomal fusion elicited by IFNc eliminates chlamydial inclusions.
IFNc-induced autophagy is required for the elimination of C. trachomatis IFNc can induce autophagy to eliminate intracellular pathogens [13, 14] . We hypothesized that IFNc induces the interaction of C. trachomatis inclusions with autophagosomes to reroute the intruder to the lysosomal compartment for destruction; therefore, we transfected MEFs with the autophagosome-associated marker GFP-LC3, a GFP fusion with the microtubule-associated protein light chain 3 (LC3). Then, MEFs were either infected with C. trachomatis or C. muridarum in the presence or absence of IFNc. In contrast to IFNc-untreated cells, GFP-LC3 colocalized strongly to C. trachomatis inclusions (74%) in IFNc treated cells ( Figure 3E and F). However, minimal GFP-LC3 colocalization was observed in C. muridarum inclusions (Figure S2C and D). Taken together with our LAMP1 data, these findings clearly suggest the nature of C. trachomatis inclusions upon IFNc stimulation is autolysosomal.
To further support our hypothesis, we used Atg5-deficient (Atg52/2) MEFs (Atg, autophagy-related). Atg5 is a crucial factor in autophagosome formation as its deletion prevents their appearance [29] . We infected Atg52/2 MEFs with either C. trachomatis or C. muridarum (MOI 1) for 48 h in the presence or absence of IFNc. IFNc treatment did not affect chlamydial growth as inclusion size and recovery of infectious progeny in these cells were comparable to those of untreated knockout cells ( Figure 4A and B) and WT MEFs. The completion of chlamydial development in cells devoid of autophagy shows that host cell resistance to chlamydial inclusions depends on their fusion with autophagosomes. Furthermore, subcellular analysis of cultures at 3 h p.i. with LAMP1 revealed that lysosomal fusion is blocked in Atg52/2 MEFs ( Figure 4C and D) . Thus, fusion of C. trachomatis inclusions with autophagosomes is a prerequisite for lysosomal degradation.
Association of Irga6 with early chlamydial inclusions is blocked in Atg52/2 MEFs in response to IFNc
To address the role of IFNc-induced IRGs in the regulation of C. trachomatis survival, we examined the intracellular distribution of IRGs at 3 h p.i. in Atg52/2 MEFs. Surprisingly, upon IFNc stimulation most bacterial inclusions colocalized with Irgd (41%), Irgm2 (80%) and Irgm3 (79%) ( Figure 5A and B) ; results comparable to data obtained from IFNc-stimulated WT MEFs (Figure 2) . Strikingly, only 2% of inclusions colocalized with Irga6 ( Figure 5B) , as compared to 83% in IFNc-treated WT MEFs ( Figure 2B ). As expected, IRG proteins did not colocalize with early inclusions of C. muridarum ( Figure S1B ). These results strongly suggest an important role for Irga6 in autophagy-mediated control of C. trachomatis infection.
Absence of Irga6 stimulates growth of C. trachomatis and induces resistance against IFNc-induced killing
To further analyze the role of Irga6 in IFNc-mediated growth restriction of C. trachomatis, we examined Irga6-knockout (Irga62/ 2) MEFs. Untreated Irga62/2 cells infected for 48 h with C. trachomatis generated larger inclusions and yielded a 4 to 5-fold increase in the number of infectious progeny, compared to untreated WT cells ( Figure 6A and B). IFNc treatment did not inhibit the growth of inclusions in Irga62/2 cells, but they were bigger than in control untreated WT MEFs ( Figure 6A) . Surprisingly, infected Irga62/2 MEFs were sensitive to IFNc exposure, which resulted in partial destruction and loss of infected host cells of the monolayer. Therefore, the chlamydial infectivity measured in each sample had to be normalized to the surviving host cells, determined via an LDH release assay (data not shown). This data clearly indicated that IFNc treatment of Irga62/2 cells did not reduce infectivity ( Figure 6B ). Irga6 is important in the induction of autophagy independent of C. trachomatis infection Is IFNc capable of activating autophagy in MEFs and is Irga6 required for IFNc-induced autophagy? To answer these questions, we used immunoblots to monitor the formation of early autophagosomal precursors and newly formed autophagosomes by following changes in LC3 expression. LC3 exists in two forms: the cytosolic LC3-I form, which has a molecular weight of approximately 18 kDa and the membrane-bound LC3-II form, with a molecular weight of 16 kDa [30] . LC3-II is bound to the membrane of nascent autophagosomes and correlates with the amount of LC3-positive autophagosomes [30] . In WT cells, LC3-II levels increased in response to IFNc stimulation ( Figure 7A, lane  3) . Notably, levels of IFNc-induced LC3-II were comparable to those induced by rapamycin (Rapa), a conventional inducer of autophagy ( Figure 7A, lane 2) . Infection with C. trachomatis for 4 h or 8 h did not influence LC3-II expression ( Figure 7A , lanes 4 and 6, respectively). However, IFNc treatment of infected WT MEFs induced an upregulation of LC3-II ( Figure 7A, lanes 5 and 7) . In general, levels of LC3 protein were substantially lower in Irga62/ 2 cells ( Figure 7C ) as compared to WT MEFs ( Figure 7A ). Moreover, IFNc or Rapa treatment had a minimal stimulatory effect on LC3 expression and/or processing in Irga62/2 cells ( Figure 7C, lanes 2, 3, 5 and 7) . C. muridarum infection effectively suppressed an increase in LC3 levels upon IFNc treatment ( Figure   S4A ). Similarly, no increase in LC3 levels upon IFNc treatment in C. muridarum infected Irga62/2 cells ( Figure S4C ) was observed. Atg52/2 cells did not process LC3 ( Figure 7B and S4B), as expected for cells that are unable to form autophagosomes [31] .
To confirm the importance of Irga6 in autophagy, we quantified the number of autophagosomes in the cytoplasm. In contrast to control untreated WT cells ( Figure 7D ), numbers of GFP-LC3-decorated structures per cell in infected and uninfected WT cells exposed to either IFNc or Rapa were increased. In agreement with our immunoblot analysis, IFNc or Rapa induction did not increase the amount of autophagosomes and we observed only low numbers of decorated vesicles in Irga62/2 cells ( Figure 7E ). These data further support a pivotal role for autophagy in C. trachomatis elimination and indicate a role for Irga6 as regulator of IFNc-induced autophagy. In summary, our data clearly demonstrates the ability of IFNc to induce autophagy in nonphagocytic MEFs. More importantly, low LC3 expression and small numbers of autophagosomes in Irga62/2 cells indicate a role for Irga6 in the regulation of the IFNc-induced autophagic pathway. Our results reveal Irga6 as an important factor in assigning chlamydial inclusions for degradation via autophagy.
Discussion
Here we elucidate the mechanisms underlying IFNc/IRGsinduced immunity to C. trachomatis in murine cells, demonstrating a pivotal role for Irga6 in mediating host resistance to infection via the induction of autophagy. We show that C. trachomatis, but not C. muridarum, inclusions strongly colocalized with 4 IRGs (Irga6, Irgd, Irgm2 and Irgm3) in response to IFNc, whereas Irgb6 colocalized in the presence or absence of the cytokine. IFNc also induced accumulation of the autophagosomal membrane marker LC3, and the lysosomal component LAMP1, suggesting a rerouting of C. trachomatis phagosomes to autolysosomes. However, autophagydeficient MEFs (Atg52/2) and WT cells with an impairment in lysosomal acidification surrendered to infection. While Irgb6, Irgd, Irgm2 and Irgm3 still localized to chlamydial inclusions in IFNcinduced Atg52/2 cells, Irga6 localization was disrupted, indicating a pivotal role for Irga6 in resistance to the microbe. Strikingly, Irga6-deficient MEFs (Irga62/2), in which chlamydial growth is enhanced compared to WT MEFs, showed no response to IFNc even though all the major IRG proteins studied still localized to inclusions. Thus, Irga6 constitutes a critical resistance factor against C. trachomatis infection in IFNc-induced MEFs that remodels a classically non-fusogenic intracellular pathogen vacuole, stimulating fusion with autophagosomes and directing the intruder to the lysosomal compartment for destruction.
Autophagy reroutes cytoplasmic material and organelles internalized into autophagosomes to lysosomes, culminating in the formation of autolysosomes and degradation of their cargo [30, 32, 33] . Similarly, this process can induce pathogen eradication. Here we showed IFNc stimulates localization of LC3 and the lysosomal marker LAMP1 to C. trachomatis, but not C. muridarum, inclusions in WT MEFs. Despite the presence of IFNc, autophagosome-deficient MEFs were highly permissive to C. trachomatis replication in a compartment disconnected from lysosomes, confirming an involvement of autophagy that leads to lysosomal degradation of the bacteria. Similarly, a study in macrophages showed that IFNc stimulates recruitment of LC3 and LAMP1 to the M. tuberculosis compartment and induces autophagy to inhibit bacterial viability [13] . In addition, the induction of structures carrying LC3 close to disrupting T. gondii vacuoles in IFN-c-induced astrocytes has been reported [24] . IFNc therefore represents a novel means to counteract the nonfusogenicity of the C. trachomatis inclusion by remodelling it into a compartment with autophagic characteristics to prompt fusion with lysosomes for degradation.
In contrast to our results, a previous study implied that IFNcmediated suppression of C. trachomatis in MECs was not the result of fusion with lysosomes, but due to a reduction of lipid trafficking to inclusions [28] . This discrepancy can be explained by the fact that our LAMP1 analysis was done at 3 h p.i., a time at which most C. trachomatis early inclusions strongly colocalized with LAMP1. In contrast, Nelson and coworkers examined LAMP1 colocalization to 24 h-old inclusions, which probably represent the 20% of C. trachomatis inclusions that might partially have survived the IFNc-mediated immunity. Nevertheless, we cannot dismiss a role for lipid and nutrient, or indeed other vacuolar trafficking in the IFNc-mediated suppression of Chlamydial growth. For instance, it has been shown that Irga6 interacts with the microtubule-binding protein hook3; therefore, it is tempting to consider that Irga6 participates in the modulation of intracellular membrane-dependent processes [34, 46] like vesicular trafficking and interactions with the pathogen-containing vacuolar membrane components.
Several studies have implicated the IRG family of proteins in growth regulation of intracellular pathogens [13, 14, 19, 35] . For instance, Irga6 is required for resistance against T. gondii in cultured murine astrocytes by activating vacuole vesiculation [24] . A role for Irga6 in the induction of structures carrying LC3 close to disrupting T. gondii vacuoles upon IFNc-treatment has also been suggested [24] . Similarly, Irgm3 induces T. gondii vacuole vesiculation and fusion with autophagosomes in macrophages activated in vivo [23] . Recently, siRNA targeting of Irga6 was shown to partially revert the IFNc-induced growth inhibition of C. trachomatis, whereas siRNA-mediated knockdown of Irgb6, Irgd, Irgm1, Irgm2 or Irgm3 did not [28] . In support of these data, we uncover Irga6 as a major effector protein in IFNc-induced elimination of C. trachomatis. Despite an accumulation of other IRG members at the C. trachomatis inclusion in Irga62/2 cells, C. trachomatis grow more efficiently than in WT MEFs. Similarly, an analysis of isolated Irga62/2 astrocytes showed a significant loss of resistance to T. gondii, even though Irgb6, Irgd, Irgm2 and Irgm3 still localized to the parasitophorous vacuole [24] . Additionally, C. trachomatis inclusions in Irga62/2 cells do not colocalize with LAMP1 and LC3, confirming an involvement of autophagy in restricting pathogen growth. In T. gondii, it has been proposed that autophagic sequestration follows damage to the vacuolar membrane containing the organism [23] , but it is not yet known whether such damage or a molecular modification of the target membrane leads to autophagic uptake. The present study clearly shows that molecular remodelling of the chlamydial inclusion membrane in response to IFNc stimulation promotes fusion with autophagosomes.
There is some evidence that GMS subfamily proteins (Irgm1, Irgm2 and Irgm3) are required for the normal function of Irga6 [16] . When overexpressed in cells not stimulated with IFNc, Irga6 and Irgb6 intracellularly mislocalized and aggregated. This mislocalization could be corrected by co-expression of Irgm1, Irgm2 and Irgm3. Another line of evidence shows that IRG proteins accumulate on the T. gondii vacuole in a cooperative manner to regulate anti-parasitic Irga6 function [36] . The assembly of Irga6, Irgb6, Irgd, Irgm2 and Irgm3 on C. trachomatis inclusions in WT MEFs and the lack of Irgm1 colocalization observed in this study is largely consistent with IRGs after infection of murine astrocytes with T. gondii [24] . The function of Irgm1, however, does not necessarily require its direct association with the microbial vacuole. Indeed, Irgm1-deficient mice are susceptible to C. trachomatis [37] , T. gondii [38] , T. cruzi [39] and M. tuberculosis [19] infection. The role of the other IRGs may be to induce the accumulation of effective Irga6 concentrations and/or its correct positioning for autophagosome remodelling. Recent work has demonstrated an essential role for Atg5, independent of autophagy, in trafficking Irga6 to vacuole membranes of T. gondii and subsequent pathogen clearance [40] . Here, we also found recruitment of Irga6 was linked to Atg5, in an autophagy dependent manner, as accumulation of Irga6 at early chlamydial inclusions was blocked in Atg52/2 MEFs. Future experiments will define the importance of these factors in recruitment of Irga6 to the inclusion and its antimicrobial function.
The inhibitory effects of IFNc on chlamydial replication have been extensively studied, revealing marked inconsistencies in chlamydial strain susceptibility and antichlamydial effector mechanisms, as demonstrated by discrepancies in the role of IRGs in controlling chlamydial infections. Both Irgm3 and Irgb10 were found to mediate resistance to C. trachomatis in cultures and in systemically infected mice [20] . Irgm2 and Irgb10 have been implicated in C. psittaci resistance in cell cultures and locally infected mice [41] . In agreement with our study, Nelson and coworkers suggested a crucial role for Irga6 in C. trachomatis growth control [28] . In contrast, it was recently shown that Irga62/2 MEFs are not defective, but more efficient in restricting growth of C. trachomatis compared with control IFNc-treated MEFs [37] . Subcellular localization studies only partly agree with our data, showing Irga6 localization and the absence of Irgm1 localization to inclusions upon IFNc stimulation [20] . Also, Bernstein-Hanley and coworkers detected no Irgm3 at the C. trachomatis inclusion and the bacterium's growth in systemically infected mice was not affected; it remains unclear why resistance is not affected in Irga62/2 mice. More specific infection of the uterine mucosa by intrauterine inoculation with human chlamydial strains, as previously described [42] , might lead to a more coherent outcome. Overall, these studies point to the complexity and diversity of IRGs that participate in host resistance mechanisms. The pleiotropic signaling capabilities and host and tissue specificities of IFNc [43] , the genomic differences among chlamydial strains studied [44, 45] , differences in susceptibility among inbred mouse strains and the inherent experimental variation between laboratories, may account for these discrepancies.
It is indisputable that C. muridarum possesses a very effective mechanism to evade the murine IFNc response, unlike C. trachomatis; however, the underlying mechanism remains largely hypothetical. Nelson and co-workers suggested a gene in the plasticity zone of C. muridarum, which is absent in C. trachomatis, is responsible for avoiding the Irga6-mediated growth inhibition by C. muridarum in murine cells [28] . This gene encodes a relatively large protein with a homology to a clostridial toxin and the Yersinia YopT virulence factor. YopT acts as cysteine protease that can inactivate Rho GTPase by the cleavage of the GTPase and its subsequent release from the membrane. Although indirect, the authors suggested that a C. muridarum hypothetical large toxin inactivates Irga6 by a similar mechanism. In contrast to our work, a recent study demonstrated the transient overexpression of Irgb10 in the absence of IFNc was sufficient to reduce the yield of C. trachomatis, but not C. muridarum [37] . Overexpressed Irgb10 was found associated with C. trachomatis inclusions only. Based on this differential subcellular localization of Irgb10 in infected cells, the authors proposed Irgb10 is recruited to the inclusion to induce bacterial growth blockage. They also suggested that C. muridarum is protected from IFNc-induced immune response by a mechanism that restricts access of Irgb10 to its inclusion. Here we show IFNcstimulated association of different IRG proteins (Irga6, Irgb6, Irgd, Irgm2 and Irgm3) with inclusions harbouring C. trachomatis, but not C. muridarum. Importantly, Irga6 was found to be the critical effector protein responsible for immune resistance to C. trachomatis, while other IRGs could have cooperative interactions. Cells deficient in Irga6 were highly permissive to C. trachomatis infection, although other IRGs were recruited in response to IFNc. However, C. muridarum inclusions did not associate with any of these IRGs. These results strongly indicate that C. muridarum can prevent, by a yet undefined mechanism, not only the access and/ or the activity of the effector Irga6, but also the localization of the so called 'co-operative' IRGs required for the anti-bacterial function of Irga6.
Our data indicate that modification of the inclusion is critical to the outcome of the host-parasite interaction; the presence of Irga6 on the inclusion membrane defeats the complex array of processes by which C. trachomatis seeks to delay phagosomal maturation. Further work will now unravel the precise mechanism(s) through which Irga6 promotes IFNc -induced C. trachomatis elimination and C. muridarum uses to escape the murine IFNc-induced response.
Methods

Chemicals and antibodies
RPMI-1640 medium and Dulbecco's minimal essential medium (DMEM) were purchased from Gibco-Invitrogen (Karlsruhe, Germany). Cycloheximide was obtained from Calbiochem (Darmstadt, Germany). IFNc was purchased from Strathmann Biotec Gmbh. (Hamburg, Germany). Bafilomycin A1 (Baf A1) was purchased from Calbiochem. Rapamycin (Rapa) was obtained from Sirolimus LC Laboratories (Massachusetts, USA). Goat antibodies raised against mouse Irgb6 (clone A-20), Irgm2 (clone L-15), Irgm3 (clone Y-16), and Irgm1 (clone A-19), in addition to the rabbit antibody against mouse Irgd (clone M-85), were purchased from Santa Cruz Biotechnology, Inc. (Heidelberg, Germany). Other serological reagents used were: monoclonal antimouse Irga6 antibody raised in mice (clone 10D7 [46] ), rat antimouse lysosomal associated membrane protein 1 (LAMP1) (clone 1D4B; Abcam, Cambridge, UK), monoclonal antibody to light chain 3 (LC3) (clone 5F10; purchased from nanoTools, Teningen, Germany), mouse monoclonal anti-human b-actin (Sigma-Aldrich), rabbit polyclonal anti-Chlamydia genus-specific antibody (Milan Analytica AG, La Roche, Switzerland), and mouse monoclonal anti-C. trachomatis hsp60 (Alexis, Loerrach, Germany) and LPS (clone CF6J12, Abcam, Cambridge, UK). The IMAGEN kit for detection of Chlamydia was from DAKO (Hamburg, Germany). Secondary labeled antibodies for immunofluorescence and Western analyses were purchased from Molecular ProbesMoBiTech (Goettingen, Germany), Dianova (Hamburg, Germany), BD Biosciences-Pharmingen (Heidelberg, Germany), or Amersham (NJ, USA).
Chlamydia trachomatis and C. muridarum propagation and murine cell cultures C. trachomatis Lymphogranuloma venereum (LGV) serovar L2 and C. muridarum, a generous gift from Konrad Sachse (FriedrichLoeffler-Institut, Federal Research Institute for Animal Health, Jena, Germany) were routinely propagated in HeLa cells grown in RPMI-1640 medium supplemented with glutamine and 5% fetal bovine serum (FBS). Chlamydia culturing, preparation of EB stock, and estimation of inclusion forming units (IFU)/ml were conducted as previously described [47] . Wild type (WT) MEFs and autophagy-deficient (Atg5-knockout) MEFs were generously provided by Noburo Mizushima (Department of Physiology and Cell Biology, Tokyo Medical and Dental University, Tokyo Japan). Irga6-lacking MEFs were generated in-house (see below). MEFs were grown in DMEM provided with 10% FBS, 200 mM glutamine and 1 mM sodium pyruvate, and incubated at 37uC and 5% CO 2 in a humidified tissue culture chamber.
Infection of MEFs
MEFs were seeded onto 6-well-plates and incubated overnight to allow adherence. Host cells were then infected with either C. trachomatis or C. muridarum diluted in cell growth medium at an MOI of 1 and incubated at 35uC and 5% CO 2 . Two hours post infection (p.i.) cells were washed and loaded with fresh medium containing 100 or 200 U/ml IFNc. Control infected cells were not treated with the cytokine. Cell cultures were then incubated as above for 48 h.
Infectivity titration assays
Formation of infectious C. trachomatis and C. muridarum progeny in a secondary infection was assessed as described elsewhere [47] . Briefly, infected cells were mechanically destructed using glass beads. Lysates were serially diluted in IM and inoculated onto HeLa cells for 2 h. Cells were then washed and further incubated for 24 h in RPMI medium with 5% FBS and 1 mg/ml cycloheximide. Chlamydial inclusions were fixed with methanol and then immunostained with IMAGEN Chlamydia kit. Subsequently, inclusions were visualized and counted using immunofluorescence microscopy (Nikon), and infectivity of progeny was expressed as IFU/ml.
Generation of Irga6-deficient MEFs
MEFs were prepared as described previously [48] . Briefly, embryos generated from Irga62/26C57BL/6 and Irga62/ 26Irga62/2 crosses were isolated on day 13.5 of development. Placenta, membranes, visceral tissues and the head were removed from embryos and the remaining tissue was minced and trypsinized to produce single cells. Single cells were passaged twice in DMEM containing 10% FBS and then stored in liquid nitrogen for later use.
Transfection of host cells
MEFs were seeded onto coverslips in 12-well-plates and incubated overnight at 37uC and 5% CO 2 to allow adherence. MEFs were then washed once and transfected with 1 mg/ml plasmid DNA encoding pEGFP-rat LC3 (a kind gift from Tamotsu Yoshimori, Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan), using Lipofectamine 2000 (Gibco-Invitrogen) according to manufacturer's instructions. One day post-transfection, cells were stimulated for 24 h with 100 U/ml IFNc or left unstimulated (control cells) and incubated in a humidified cell culture incubator. Next, transfected cells were infected with C. trachomatis or C. muridarum at a MOI of 5 and incubated for time periods as indicated at 35uC and 5% CO 2 , before processing for confocal microscopy and Western blotting. For colocalization studies MEFs were stained 3 h p.i. (MOI 5), facilitating the detection of a large number of intracellular bacteria before eradication in response to IFNc.
Fluorescence confocal microscopy
MEFs were plated onto coverslips in 12-well-plates at a density of 2610 5 cells per well and incubated overnight. Next, cells were treated with 100 U/ml IFNc for 24 h before infection or left untreated as a control. MEFs were then inoculated with C. trachomatis at a MOI of 5 and incubated at 35uC and 5% CO 2 . Two hours p.i., cells were washed, provided with fresh medium with or without IFNc, and incubated as before. At indicated time points, cells were fixed and permeabilized with ice-cold methanol for 5 min at room temperature (RT). In some experiments, cells were fixed for 25 min with 4% paraformaldehyde at RT, permeabilized with either 0.2% saponin, 0.3% Triton-1006 or digitonin and blocked using 2.5% BSA. Cells were sequentially incubated for 1 h at RT with primary and secondary antibodies. Then, coverslips were mounted onto glass slides using Mowiol and examined by Leica TCS-SP laser scanning confocal microscope equipped with a krypton/argon laser. Photomicrographs were processed using Adobe Photoshop 6.0 (Adobe Systems) and Microsoft Power-Point.
Immunoblotting
MEFs were stimulated with IFNc, as indicated above, or with the classical autophagy inducer Rapa at a concentration of 100 nM for 2 h. In some experiments, unstimulated and IFNcstimulated cells were infected with C. trachomatis or C. muridarum for either 3 or 8 h. Cells were washed with cold PBS, and lysed for 30 min on ice in Triton-1006 lysis buffer (20 mM Tris-HCl; pH 7.6, 150 mM NaCl, 1% Triton-100X), containing 2 mM PMSF and complete protease inhibitor cocktail (Roche). The lysates were then centrifuged at 8,0006g for 10 min. Equal amounts of proteins were subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE). Protein bands were transferred electrophoretically onto Immobilon-P polyvinylidene difluoride membranes (Millipore, MA, USA). The membranes were blocked with 5% fat-skim milk in TBS (Tris-buffered saline; pH 7.5), containing 0.05% Tween-20 for 1 h at RT. Next, membranes were incubated with the monoclonal mouse anti-LC3 (overnight, at 4uC) or anti-b-actin (1 h at RT) diluted in TBS-0.05% Tween-20. Membranes were washed and then incubated with secondary antibodies conjugated with horseradish peroxidase. Signal detection was performed with the enhanced chemiluminescence system (ECL, Amersham).
Inhibition of lysosomal acidification
MEFs were seeded onto coverslips and exposed to IFNc for 23 h. MEFs were pretreated with 100 nM Baf A1 for 1 h before the infection. Cells were then inoculated with C. trachomatis (MOI of 5), and continuously incubated with Baf A1 throughout the experiment period. Control cell monolayers were treated with dimethylsulfoxide, in which Baf A1 was dissolved. Specimens were then fixed and double stained for LAMP1 and C. trachomatis. The percentages of colocalization of chlamydial inclusions with LAMP1 were determined in the presence or absence of the inhibitor.
To examine the effect of the acidification inhibition on the recovery of infectious chlamydial progeny, cells were grown in 6-well-plates, treated, and infected as mentioned above. Cells were then harvested 2 days p.i., lysed and diluted, and formation of infectious C. trachomatis was assessed by infectivity titration assays on fresh HeLa cell cultures.
Assessment of host cell viability
Lactate dehydrogenase (LDH) colorimetric assay (Roche Diagnostics, Mannheim, Germany) was used according to manufacturer's instructions. This assay is based on the measurement of LDH activity released from the cytosol of damaged cells into the supernatant. 
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